drugset / Trial / NCT00841698

Paroxetine Hydrochloride 40 mg Tablets Under Fasting Conditions

NCT00841698

Phase 1 Completed 50 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study is to compare the rate and extent of absorption of paroxetine hydrochloride 40 mg film-coated tablets (test) versus Paxil® (reference) administered as 1 x 40 mg film-coated tablet under fasting conditions.

Timeline

Start
2002-10
Primary completion
2002-10
Completion
2002-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Paroxetine Small molecule 40 mg

Indications

No indication recorded.